Systemic immune aberrations in Alzheimer's disease patients.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Neuroimmunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.JNEUROIM.2007.10.020PMID 18037502
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunophenotypes in the circulation of patients with mild cognitive impairment.

  2008cited by this paper
• T-cells in alzheimer’s disease

  2007cited by this paper
• Altered lymphocyte distribution in Alzheimer's disease.

  2007cited by this paper
• Increased production of inflammatory cytokines in mild cognitive impairment.

  2007cited by this paper
• Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia.

  2007cited by this paper
• Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease.

  2007cited by this paper
• Amaigrissement et cytokines circulantes chez des patients souffrant d’une maladie d’Alzheimer

  2006cited by this paper
• [Relationships between weight loss and circulating cytokines in patients with Alzheimer's disease].

  2006cited by this paper
• Apoptosis of CD4+ T and natural killer cells in Alzheimer's disease.

  2006cited by this paper
• Biomarkers for Alzheimer's disease – Clinical needs and application

  2006cited by this paper
• Biomarkers of Alzheimer disease in plasma

  2004cited by this paper
• Peripheral cytokine release in Alzheimer patients: correlation with disease severity.

  2003cited by this paper
• High Circulating Levels of Tumor Necrosis Factor-α in Centenarians Are Not Associated with Increased Production in T Lymphocytes

  2003cited by this paper
• Age-related inflammatory cytokines and disease.

  2003cited by this paper
• Peripheral inflammatory response in Alzheimer's disease and multiinfarct dementia.

  2002cited by this paper
• Proinflammatory cytokines in sera of elderly patients with dementia: levels in vascular injury are higher than those of mild-moderate Alzheimer's disease patients.

  2002cited by this paper
• Comparison of Serum and Cell-Specific Cytokines in Humans

  2001cited by this paper
• Inflammation, autotoxicity and Alzheimer disease.

  2001cited by this paper
• Cytokine production consequent to T cell--microglia interaction: the PMA/IFN gamma-treated U937 cells display similarities to human microglia.

  2001cited by this paper
• The role of TNF and its receptors in Alzheimer's disease.

  2001cited by this paper
• Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?

  2000cited by this paper
• Inflammation and Alzheimer's disease.

  2000cited by this paper
• Neuro-Immune Interactions in Neurologic and Psychiatric Disorders

  2000cited by this paper
• Contributions of the Glial Injury Response to the Multifactorial Pathogenesis of Alzheimer’s Disease

  2000cited by this paper
• Neuronal Control of the Immune Response in the Central Nervous System: From Pathogenesis to Therapy

  2000cited by this paper
• Intracerebral Production of Tumor Necrosis Factor-α, a Local Neuroprotective Agent, in Alzheimer Disease and Vascular Dementia

  1999cited by this paper
• A high plasma concentration of TNF-alpha is associated with dementia in centenarians.

  1999cited by this paper
• Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals.

  1999cited by this paper
• Biomarkers of Alzheimer disease.

  1999cited by this paper
• Consensus report of the working group on: 'Molecular and biochemical markers of Alzheimer's disease'

  1998cited by this paper
• T lymphocyte subpopulations and activation markers correlate with severity of Alzheimer's disease.

  1995cited by this paper
• Correlation of cytokine secretion by mononuclear cells of Alzheimer patients and their disease stage.

  1994cited by this paper
• Elevated circulating tumor necrosis factor levels in Alzheimer's disease.

  1991cited by this paper
• Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.

  1989cited by this paper
• Criteria for the Clinical Diagnosis of Alzheimer's Disease Excerpts from the NINCDS‐ADRDA Work Group Report

  1985cited by this paper

• White Blood Cells in Neurodegenerative Diseases in the Context of Neuroinflammation

  2025cites this paper
• Deciphering genetic causality between plasma BDNF and 91 circulating inflammatory proteins through bidirectional mendelian randomization

  2025cites this paper
• Serum and Saliva Biomolecules in Periodontitis Patients with and without Alzheimer's Disease.

  2025cites this paper
• Is Adipose Tissue Inflammation the Culprit of Obesity‐Associated Comorbidities?

  2025cites this paper
• Inflammatory Markers and their Relationship with Cognitive Function in Alzheimer’s Disease and Mild Cognitive Impairment. Systematic Review and Meta-Analysis

  2025cites this paper
• Adaptive immunity in the neuroinflammation of Alzheimer’s disease

  2025cites this paper
• Navigation Between Alzheimer’s Disease (AD) and Its Various Pathophysiological Trajectories: The Pathogenic Link to Neuroimmunology—Genetics and Neuroinflammation

  2025cites this paper
• Knee arthroplasty can preserve cognitive function in patients with severe knee osteoarthritis

  2025cites this paper
• Immune Profiling in Early Cognitive Disorders (IMPRINT) study protocol: a longitudinal cohort study exploring biomarkers of inflammation in early dementia with Lewy bodies and Alzheimer’s disease, as part of the Dementias Platform UK

  2025cites this paper
• Correlation of brain tissue volume loss with inflammatory biomarkers IL1β, P-tau, T-tau, and NLPR3 in the aging cognitively impaired population

  2024cites this paper
• Correlative factors of poor prognosis and abnormal cellular immune function in patients with Alzheimer’s disease

  2024cites this paper
• Ad-derived bone marrow transplant induces proinflammatory immune peripheral mechanisms accompanied by decreased neuroplasticity and reduced gut microbiome diversity affecting AD-like phenotype in the absence of Aβ neuropathology.

  2024cites this paper
• Systemic inflammatory markers and their association with Alzheimer’s disease: A cross-sectional analysis

  2024cites this paper
• Biomarkers of chronic inflammation and cognitive decline: A prospective observational study

  2024cites this paper
• Diagnostic accuracy of interleukin-6, interleukin-10 and tumor necrosis factor alpha cytokine levels in patients with mild cognitive impairment: systematic review and meta-analysis

  2024cites this paper
• No association between markers of systemic inflammation and endothelial dysfunction with Alzheimer’s disease progression: a longitudinal study

  2024cites this paper
• Plasma cytokines profile in patients with Alzheimer’s and Parkinson’s Disease: a comparative study in terms of inflammation

  2023cites this paper
• Association of inflammation and cognition in the elderly: A systematic review and meta-analysis

  2023cites this paper
• Low-dose IL-2 Treatment Rescues Cognitive Deficits by Repairing the Imbalance Between Treg and Th17 Cells at the Middle Alzheimer’s Disease Stage

  2023cites this paper
• Neuroplastic and Pro-cognitive Effects of Granulocyte Colony Stimulating Factor in Healthy Adults: A Pilot Study

  2023cites this paper
• Blood and CSF chemokines in Alzheimer’s disease and mild cognitive impairment: a systematic review and meta-analysis

  2023cites this paper
• B lymphocytes ameliorate Alzheimer's disease-like neuropathology via interleukin-35.

  2022cites this paper
• Crossing borders in Alzheimer's disease: a T cell's perspective.

  2022cites this paper
• Peripheral Inflammatory Biomarkers of Alzheimer’s Disease

  2022cites this paper
• Association of Peripheral Blood Cell Profile With Alzheimer's Disease: A Meta-Analysis

  2022cites this paper
• Inflammation at the crossroads of COVID-19, cognitive deficits and depression

  2022cites this paper
• Neuro faces of beneficial T cells: essential in brain, impaired in aging and neurological diseases, and activated functionally by neurotransmitters and neuropeptides

  2022cites this paper
• Acquired immunity and Alzheimer's disease

  2022cites this paper
• Dysregulation of Systemic Immunity in Aging and Dementia

  2021cites this paper
• Identifying the Main Functional Pathways Associated with Cognitive Resilience to Alzheimer’s Disease

  2021cites this paper
• Blood-Based Biomarkers of Neuroinflammation in Alzheimer’s Disease: A Central Role for Periphery?

  2021cites this paper
• Analysis of Immune Dysfunction and Predictors of Poor Prognosis in Patients with Alzheimer's Disease

  2021cites this paper
• The oral microbiome and inflammation in mild cognitive impairment.

  2021cites this paper
• Decreased blood CD4+ T lymphocyte helps predict cognitive impairment in patients with amyotrophic lateral sclerosis

  2021cites this paper
• The clinical correlation of proinflammatory and anti-inflammatory biomarkers with Alzheimer disease: a meta-analysis

  2021cites this paper
• Neutrophils and Macrophages as Targets for Development of Nanotherapeutics in Inflammatory Diseases

  2020cites this paper
• Pulmonary B cells ameliorate Alzheimer’s disease-like neuropathology

  2020cites this paper
• Peripheral immunophenotype in dementia with Lewy bodies and Alzheimer’s disease: an observational clinical study

  2020cites this paper
• Peripheral adaptive immunity of the triple transgenic mouse model of Alzheimer’s disease

  2019influential citation
• Peripheral inflammatory biomarkers in Alzheimer’s disease: a brief review

  2019influential citation
• The exploration of novel Alzheimer's therapeutic agents from the pool of FDA approved medicines using drug repositioning, enzyme inhibition and kinetic mechanism approaches.

  2019cites this paper
• CREB signals as PBMC-based biomarkers of cognitive dysfunction: A novel perspective of the brain-immune axis.

  2019cites this paper
• Association of Vitamin D Status with Chronic Disease Risk Factors and Cognitive Dysfunction in 50–70 Year Old Adults

  2019cites this paper
• [11C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy

  2018cites this paper
• Impairment of Several Immune Functions and Redox State in Blood Cells of Alzheimer’s Disease Patients. Relevant Role of Neutrophils in Oxidative Stress

  2018cites this paper
• Brain, Behavior and Immunity Inflammatory markers of CHMP2B mediated frontotemporal dementia

  2018cites this paper
• Relationship of systemic inflammation and cellular immunity with advancement of cognitive decline in patients with Alzheimer's disease

  2018cites this paper
• IL-1β, IL-6, TNF- α and CRP in Elderly Patients with Depression or Alzheimer’s disease: Systematic Review and Meta-Analysis

  2018cites this paper
• Inflammatory markers of CHMP2B-mediated frontotemporal dementia.

  2018cites this paper
• Immune Senescence and Inflammaging in Neurological Diseases

  2018cites this paper
• Cerebrospinal Fluid and Plasma Levels of Inflammation Differentially Relate to CNS Markers of Alzheimer’s Disease Pathology and Neuronal Damage

  2018cites this paper
• Apolipoprotein E4, Gender, Body Mass Index, Inflammation, Insulin Resistance, and Air Pollution Interactions: Recipe for Alzheimer’s Disease Development in Mexico City Young Females

  2017cites this paper
• Peripheral inflammatory markers in Alzheimer’s disease: a systematic review and meta-analysis of 175 studies

  2017cites this paper
• Similarity and Differences in Inflammation-Related Characteristics of the Peripheral Immune System of Patients with Parkinson’s and Alzheimer’s Diseases

  2017cites this paper
• Immune biomarkers in older adults: Role of physical activity

  2017cites this paper
• Untersuchungen zur Analytik und diagnostischen Aussagekraft von IL-10 und TNF-α beim Hund

  2017cites this paper
• Die Rolle der neuronalen p38α Mitogen-aktivierten Proteinkinase in der Alzheimer-Krankheit

  2017cites this paper
• Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment

  2017cites this paper
• Activity-dependent treatments for neuropathic pain

  2017cites this paper
• Targeting neuroinflammation in the treatment and prevention of Alzheimer's disease

  2017influential citation
• The Ageing Immune System and Health

  2017cites this paper
• Neuroprotective Effects of Exercise Treatments After Injury: The Dual Role of Neurotrophic Factors

  2017cites this paper
• Enhanced susceptibility of triple transgenic Alzheimer’s disease (3xTg-AD) mice to acute infection

  2017cites this paper
• Can infections cause Alzheimer’s disease?

  2017cites this paper
• Peripheral cytokines, C‐X‐C motif ligand10 and interleukin‐13, are associated with Malaysian Alzheimer's disease

  2017cites this paper
• Altered peripheral profile of blood cells in Alzheimer disease

  2017cites this paper
• Peripheral inflammation in prodromal Alzheimer’s and Lewy body dementias

  2017cites this paper
• Impact of Cytokines and Chemokines on Alzheimer’s Disease Neuro-pathological Hallmarks

  2017cites this paper
• Decreased IL-8 levels in CSF and serum of AD patients and negative correlation of MMSE and IL-1β

  2016cites this paper
• Lymphocytes in Alzheimer's disease pathology: Altered signaling pathways.

  2016cites this paper
• Interleukin-1β Promoter Polymorphism Enhances the Risk of Sleep Disturbance in Alzheimer’s Disease

  2016cites this paper
• An overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levels.

  2016cites this paper
• The role of hypertension and inflammation on the cognitive symptoms of Alzheimer's disease patients

  2016cites this paper
• Immune aging, dysmetabolism, and inflammation in neurological diseases

  2015cites this paper
• Dendritic and Langerhans cells respond to Aβ peptides differently: implication for AD immunotherapy

  2015cites this paper
• Peripheral leukocyte populations and oxidative stress biomarkers in aged dogs showing impaired cognitive abilities

  2015cites this paper
• CXCL1 Triggers Caspase-3 Dependent Tau Cleavage in Long-Term Neuronal Cultures and in the Hippocampus of Aged Mice: Implications in Alzheimer's Disease.

  2015cites this paper
• Potential benefits of mindfulness-based interventions in mild cognitive impairment and Alzheimer's disease: an interdisciplinary perspective.

  2015cites this paper
• Tumor necrosis factor-a −308 G/A polymorphism in a sample of Egyptian patients with Alzheimer′s disease

  2015cites this paper
• Compensatory Mechanisms and T Cell Migration In Mouse Models of Dopaminergic Loss

  2015influential citation
• Cellular and humoral immunity indicators in dementia of the Alzheimer ’ s type and vascular dementia

  2015cites this paper
• The role of immunity and neuroinflammation in genetic predisposition and pathogenesis of Alzheimer’s disease

  2015cites this paper
• Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: a systematic review of biomarker studies.

  2014cites this paper
• Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review.

  2014influential citation
• Air pollution and your brain: what do you need to know right now

  2014cites this paper
• Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer’s Disease: a Comparative Overview

  2014cites this paper
• Neuroprotective effects of physical activity on the brain: a closer look at trophic factor signaling

  2014cites this paper
• The Potential Role of Chemokines in Alzheimer’s Disease Pathogenesis

  2014cites this paper
• Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders

  2014cites this paper
• Alzheimer's disease and periodontitis--an elusive link.

  2014cites this paper
• Mild Cognitive Impairment with Associated Inflammatory and Cortisol Alterations as Independent Risk Factor for Postoperative Delirium

  2014cites this paper
• Alzheimer's Disease and HLA-A2: Linking Neurodegenerative to Immune Processes through an In Silico Approach

  2014cites this paper
• Why Vitamin D in Alzheimer's Disease? The Hypothesis

  2014cites this paper
• Serum cytokine profile in Alzheimer's disease patients after ingestion of an antioxidant beverage.

  2014cites this paper
• BDNF, TNFα, HSP90, CFH, and IL-10 Serum Levels in Patients with Early or Late Onset Alzheimer's Disease or Mild Cognitive Impairment

  2013cites this paper
• Increased Basal and Alum-Induced Interleukin-6 Levels in Geriatric Patients Are Associated with Cardiovascular Morbidity

  2013cites this paper
• Butyrylcholinesterase genotype and gender influence Alzheimer's disease phenotype

  2013cites this paper
• Aging enhances release of exosomal cytokine mRNAs by A (cid:1) 1-42 -stimulated macrophages

  2013cites this paper
• Investigation of five polymorphic DNA markers associated with late onset Alzheimer disease

  2013cites this paper
• Peripheral inflammation in neurodegeneration

  2013cites this paper